Evidence map›Paper›PMID 17376907›Full record

ArticleJournal of virology2007

Identification of Hendra virus G glycoprotein residues that are critical for receptor binding.

Kimberly A Bishop, Tzanko S Stantchev, Andrew C Hickey, Dimple Khetawat, Katharine N Bossart, Valery Krasnoperov, Parkash Gill, Yan Ru Feng, Lemin Wang, Bryan T Eaton and 2 more

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 92 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. AnFrontiers in chemical biology · 2024
    Article
  10. Article
  11. Article
  12. Review
  13. Antivirals targeting paramyxovirus membrane fusion.Current opinion in virology · 2021
    Review
  14. Article
  15. Article
  16. Article
  17. Vaccines to Emerging Viruses: Nipah and Hendra.Annual review of virology · 2020
    Article
  18. Review
  19. Article
  20. Review

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Kimberly A BishopDepartment of Microbiology and Immunology, Uniformed Services University, Bethesda, MD 20814, USA.
Tzanko S Stantchev
Andrew C Hickey
Dimple Khetawat
Katharine N Bossart
Valery Krasnoperov
Parkash Gill
Yan Ru Feng
Lemin Wang
Bryan T Eaton
Lin-Fa Wang
Christopher C Broder
Australian Centre for Disease Preparedness · AUUniformed Services University of the Health Sciences · USCommonwealth Scientific and Industrial Research Organisation · AU

Funding

Nipah Virus and Hendra Virus Entry and Virion AssemblyR01AI054715 · NIAID · HENRY M. JACKSON FDN FOR THE ADV MIL/MED · PI BRODER, CHRISTOPHER C · 2006 to 2016
$3.1M
NIAID NIH HHS AI054715NIAID NIH HHS R01 AI054715
6 · The paper itself

Abstract

Hendra virus (HeV) is an emerging paramyxovirus capable of infecting and causing disease in a variety of mammalian species, including humans. The virus infects its host cells through the coordinated functions of its fusion (F) and attachment (G) glycoproteins, the latter of which is responsible for binding the virus receptors ephrinB2 and ephrinB3. In order to identify the receptor binding site, a panel of G glycoprotein constructs containing mutations was generated using an alanine-scanning mutagenesis strategy. Based on a predicted G structure, charged amino acids residing in regions that could be homologous to those in the measles virus H attachment glycoprotein known to be involved in its protein receptor interaction were targeted. Using a coprecipitation-based assay, seven single-amino-acid substitutions in HeV G were identified as having significantly impaired binding to both the ephrinB2 and ephrinB3 viral receptors: D257A, D260A, G439A, K443A, G449A, K465A, and D468A. The impairment of receptor interaction conferred a concomitant diminution in their abilities to promote membrane fusion when coexpressed with F. The G glycoprotein mutants were also recognized by three or more conformation-dependent monoclonal antibodies of a panel of five, were expressed on the cell surface, and retained their abilities to bind and coprecipitate F. Interestingly, some of these mutant G glycoproteins coprecipitated with F more efficiently than wild-type G. Taken together, these data provide strong biochemical and functional evidence that some of these residues could be part of a conformation-dependent, discontinuous, and overlapping ephrinB2 and -B3 binding domain within the HeV G glycoprotein.

Indexed as

Amino AcidsAmino Acid SubstitutionBinding SitesCell LineEphrin-B2Ephrin-B3HeLa CellsHendra VirusHumansPredictive Value of TestsProtein BindingProtein ConformationReceptors, VirusViral Envelope ProteinsAmino Acidsattachment protein GEphrin-B2Ephrin-B3Receptors, VirusViral Envelope Proteins

Identifiers

PMID17376907
PMCPMC1900305
OpenAlexW2152030241

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.